Insider: Prasad Raju Chief Financial Officer - CRISPR Therapeutics AG
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 15,565 | 0 | 15,565 |
| Value | $770,623.15 | $0.00 | $770,623.15 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 03/23/2026 | DDS | 3,708 | Direct | COM | $46.78 | $173,460.24 | 15,565 |
| 03/16/2026 | DDS | 5,848 | Direct | COM | $48.26 | $282,224.48 | 17,794 |
| 03/16/2026 | DDS | 4,021 | Direct | COM | $48.26 | $194,053.46 | 13,773 |
| 01/22/2026 | DDS | 34,972 | Direct | COM | $60.19 | $2,104,964.68 | 6,767 |
| 01/06/2026 | DDS | 5,004 | Direct | COM | $60.00 | $300,240.00 | 12,530 |
| 01/06/2026 | DDS | 18,933 | Direct | COM | $60.18 | $1,139,386.05 | 17,534 |
| 01/06/2026 | DDS | 5,763 | Direct | COM | $60.21 | $347,009.82 | 6,767 |
| 12/22/2025 | DDS | 5,472 | Direct | COM | $56.33 | $308,262.38 | 7,767 |
| 12/22/2025 | DDS | 3,528 | Direct | COM | $55.10 | $194,400.56 | 13,239 |
| 12/22/2025 | DDS | 1,000 | Direct | COM | $56.89 | $56,885.80 | 6,767 |
| 03/21/2025 | DDS | 2,197 | Direct | COM | $41.23 | $90,582.31 | 16,767 |
| 03/17/2025 | DDS | 3,762 | Direct | COM | $41.80 | $157,251.60 | 12,714 |
| 03/15/2024 | DDS | 3,524 | Direct | COM | $72.69 | $256,159.56 | 6,476 |
| 1 You are at page 1 of 1 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2026 Zacks Investment Research